Cytogam
FDA Approves Procysbi for Rare Genetic Condition »
"The U.S. Food and Drug Administration today approved Procysbi (cysteamine bitartrate) for the management of nephropathic cystinosis in children and adults. Procysbi was granted orphan product designation because it is intended to treat a rare dis"...
Read the FDA Approves Procysbi for Rare Genetic Condition article »
Cytogam
Cytogam Patient Information including How Should I Take
In this Article
- What is CMV IG (Cytogam)?
- What are the possible side effects of CMV IG (Cytogam)?
- What is the most important information I should know about CMV IG (Cytogam)?
- What should I discuss with my healthcare provider before taking CMV IG (Cytogam)?
- How should I take CMV IG (Cytogam)?
- What happens if I miss a dose (Cytogam)?
- What happens if I overdose (Cytogam)?
- What should I avoid while taking CMV IG (Cytogam)?
- What other drugs will affect CMV IG (Cytogam)?
- Where can I get more information?
What should I discuss with my healthcare provider before taking CMV IG (Cytogam)?
Do not use CMV IG without first talking to your doctor if you have
- kidney disease;
- diabetes;
- IgA deficiency; or
- a previous allergic reaction to another immune globulin product.
You may not be able to use CMV IG, or you may require a dosage adjustment or special monitoring during treatment.
CMV IG is in the FDA pregnancy category C. This means that it is not known whether it will be harmful to an unborn baby. Do not use CMV IG without first talking to your doctor if you are pregnant or could become pregnant during treatment.
It is not known whether CMV IG passes into breast milk. Do not use CMV IG without first talking to your doctor if you are breast-feeding a baby.
Individuals over the age of 65 years may have an increased risk of kidney problems with the use of CMV IG. Your doctor may prescribe a lower dose of the medication or special monitoring during treatment.
How should I take CMV IG (Cytogam)?
CMV IG will be administered by intravenous (into a vein) injection by a healthcare provider in a hospital or clinic setting.
Your doctor may want you to have blood tests or other forms of monitoring during treatment with CMV IG to monitor progress and side effects.
Your healthcare provider will store CMV IG as directed by the manufacturer. If you are storing CMV IG at home, your healthcare provider will provide storage instructions.
Additional Cytogam Information
Cytogam - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.






